XML 41 R31.htm IDEA: XBRL DOCUMENT v3.22.1
EQUITY-BASED COMPENSATION (Tables)
 3 Months Ended
Mar. 31, 2022
Share-based Payment Arrangement [Abstract]  
Schedule of restricted stock awards
The following table summarizes time-based restricted stock award activity under our Equity Plan for the three months ended March 31, 2022:
 
 Number
 of Shares		Weighted Average
Grant Date 
Fair Value		Aggregate
Current Value
  (per share)(in thousands)
Non-vested at December 31, 2021605,470 $9.98 $5,909 
Granted316,643 9.83  
Vested(227,153)(9.70) 
Forfeited(3,173)(10.29) 
Non-vested at March 31, 2022691,787 $9.85 $6,890 
The following table summarizes performance-based restricted stock activity under the Equity Plan for the three months ended March 31, 2022:
 
 Number 
of Shares		Weighted Average
Grant Date 
Fair Value (1)		Aggregate
Current Value
  (per share)(in thousands)
Non-vested at December 31, 20211,002,866 $11.92 $9,788 
Granted306,435 9.83  
Vested(302,327)(12.81) 
Forfeited— —  
Non-vested at March 31, 20221,006,974 $11.76 $10,029 

(1) The amounts included in this column represent the expected future value of the performance-based restricted stock awards calculated using the Monte Carlo simulation valuation model.
Schedule of equity-based compensation expense
Equity-based compensation expense included in Corporate general and administrative expenses in the Condensed Consolidated Statements of Operations for the three and three months ended March 31, 2022 and 2021 was as follows (in thousands):
 
 For the
Three Months Ended
March 31,
 20222021
Time-based restricted stock$992 $665 
Performance-based restricted stock2,674 904 
Director stock32 — 
 $3,698 $1,569 
Schedule of unrecognized equity-based compensation expense for all non-vested awards
Unrecognized equity-based compensation expense for all non-vested awards pursuant to our Equity Plan was $12.3 million at March 31, 2022 and will be recorded as follows (in thousands):
 
 Total2022202320242025
Time-based restricted stock$5,877 $1,954 $2,334 $1,396 $193 
Performance-based restricted stock6,378 2,159 2,552 1,458 209 
 $12,255 $4,113 $4,886 $2,854 $402